BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1436 related articles for article (PubMed ID: 19325510)

  • 1. Secondary hemophagocytic lymphohistiocytosis and severe sepsis/ systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation.
    Castillo L; Carcillo J
    Pediatr Crit Care Med; 2009 May; 10(3):387-92. PubMed ID: 19325510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An unusual cause of multiple organ dysfunction syndrome in the pediatric intensive care unit: hemophagocytic lymphohistiocytosis.
    Karapinar B; Yilmaz D; Balkan C; Akin M; Ay Y; Kvakli K
    Pediatr Crit Care Med; 2009 May; 10(3):285-90. PubMed ID: 19433941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High elevated ferritin levels and the diagnosis of HLH/Sepsis/SIRS/MODS/MAS.
    Castillo L
    Pediatr Blood Cancer; 2008 Nov; 51(5):710; author reply 710-1. PubMed ID: 18615508
    [No Abstract]   [Full Text] [Related]  

  • 4. Malignancy-associated hemophagocytic lymphohistiocytosis in pediatric cases: a multicenter study from Turkey.
    Celkan T; Berrak S; Kazanci E; Ozyürek E; Unal S; Uçar C; Yilmaz S; Gürgey A
    Turk J Pediatr; 2009; 51(3):207-13. PubMed ID: 19817262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?
    Demirkol D; Yildizdas D; Bayrakci B; Karapinar B; Kendirli T; Koroglu TF; Dursun O; Erkek N; Gedik H; Citak A; Kesici S; Karabocuoglu M; Carcillo JA;
    Crit Care; 2012 Dec; 16(2):R52. PubMed ID: 22715953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of the hemophagocytic lymphohistiocytosis-associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis.
    Hazen MM; Woodward AL; Hofmann I; Degar BA; Grom A; Filipovich AH; Binstadt BA
    Arthritis Rheum; 2008 Feb; 58(2):567-70. PubMed ID: 18240215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemophagoctic lymphohistiocytosis--recent concept.
    Bhattacharyya M; Ghosh MK
    J Assoc Physicians India; 2008 Jun; 56():453-7. PubMed ID: 18822626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood macrophage activation syndrome differs from infection-associated hemophagocytosis syndrome in etiology and outcome in Taiwan.
    Chen HH; Kuo HC; Wang L; Yu HR; Shen JM; Kwang KP; Yang KD
    J Microbiol Immunol Infect; 2007 Jun; 40(3):265-71. PubMed ID: 17639169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection.
    Shapiro N; Howell MD; Bates DW; Angus DC; Ngo L; Talmor D
    Ann Emerg Med; 2006 Nov; 48(5):583-90, 590.e1. PubMed ID: 17052559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.
    Henter JI; Horne A; Aricó M; Egeler RM; Filipovich AH; Imashuku S; Ladisch S; McClain K; Webb D; Winiarski J; Janka G
    Pediatr Blood Cancer; 2007 Feb; 48(2):124-31. PubMed ID: 16937360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Causes, clinical symptoms, and outcomes of infectious diseases associated with hemophagocytic lymphohistiocytosis in Taiwanese adults.
    Tseng YT; Sheng WH; Lin BH; Lin CW; Wang JT; Chen YC; Chang SC
    J Microbiol Immunol Infect; 2011 Jun; 44(3):191-7. PubMed ID: 21524613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemophagocytic lymphohistiocytosis--a contemporary medical problem].
    Machaczka M
    Pol Merkur Lekarski; 2012 Jan; 32(187):59-63. PubMed ID: 22400183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemophagocytic lymphohistiocytosis: a potentially underrecognized association with systemic inflammatory response syndrome, severe sepsis, and septic shock in adults.
    Raschke RA; Garcia-Orr R
    Chest; 2011 Oct; 140(4):933-938. PubMed ID: 21737492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemophagocytic syndromes.
    Janka GE
    Blood Rev; 2007 Sep; 21(5):245-53. PubMed ID: 17590250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial changes in neutrophil-endothelial activation markers during the course of sepsis associated with disseminated intravascular coagulation.
    Gando S; Kameue T; Matsuda N; Hayakawa M; Hoshino H; Kato H
    Thromb Res; 2005; 116(2):91-100. PubMed ID: 15907522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children*.
    Rajasekaran S; Kruse K; Kovey K; Davis AT; Hassan NE; Ndika AN; Zuiderveen S; Birmingham J
    Pediatr Crit Care Med; 2014 Jun; 15(5):401-8. PubMed ID: 24583503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study of systemic inflammatory response syndrome and multiple organ dysfunction syndrome in critically patients].
    Qiu H; Du B; Liu D
    Zhonghua Wai Ke Za Zhi; 1997 Jul; 35(7):402-5. PubMed ID: 10677973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage Activation-Like Syndrome: A Distinct Entity Leading to Early Death in Sepsis.
    Karakike E; Giamarellos-Bourboulis EJ
    Front Immunol; 2019; 10():55. PubMed ID: 30766533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic inflammatory response syndrome in diseases of the skin.
    Thomas M; Peter JV; Williams A; Job V; George R
    Postgrad Med J; 2010 Feb; 86(1012):83-8. PubMed ID: 20145056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection Associated Secondary Hemophagocytic Lymphohistiocytosis in Sepsis Syndromes - A Tip of an Iceberg.
    Agarwal A; Agarwal A
    J Assoc Physicians India; 2016 Oct; 64(10):44-50. PubMed ID: 27766802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 72.